SCHEMBL19388323

SCHEMBL19388323

CC(C)C(N)C(=O)N[C@H](c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H](NC(=O)C(N)C(C)C)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 1/20 0.41
▸ MMP1 P03956 1/20 0.40
▸ MMP3 P08254 1/20 0.40
▸ MMP7 P09237 1/20 0.40
▸ CIT O14578 1/20 0.39
▸ S1PR4 O95977 1/20 0.37
▸ S1PR1 P21453 1/20 0.37
▸ S1PR3 Q99500 1/20 0.37
▸ S1PR5 Q9H228 1/20 0.37
▸ KMT2A Q03164 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ ABCB11 O95342 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ OPRD1 P41143 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15116536 1.00 PRCP (0.41) PRCPMMP1MMP3MMP7CIT
SCHEMBL15125109 0.90 CIT (0.36) PRCPMMP1MMP3MMP7CIT
SCHEMBL15111977 0.82 MMP1 (0.39) MMP1MMP3MMP7S1PR4S1PR1
SCHEMBL19184987 0.81 MMP1 (0.47) MMP1MMP3MMP7
SCHEMBL16408060 0.81 MMP1 (0.47) MMP1MMP3MMP7
SCHEMBL15105790 0.80 S1PR4 (0.36) MMP1MMP3MMP7S1PR4S1PR1
SCHEMBL13758829 0.78 SSTR3 (0.50) MMP1MMP3MMP7NR1I2ABCB11
SCHEMBL13294146 0.78 SSTR3 (0.50) MMP1MMP3MMP7NR1I2ABCB11
SCHEMBL13758689 0.78 SSTR3 (0.50) MMP1MMP3MMP7NR1I2ABCB11
SCHEMBL18438936 0.77 MMP1 (0.49) MMP1MMP3MMP7OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 — — EP disclosed
US-9770439-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-26 — — US disclosed
Send feedback